Two Chinese Medical-Device Makers Declare Bankruptcy After Winning Bulk-Buying Bids
Listen to the full version

Two Chinese medical device firms have declared bankruptcy after successfully winning bids in a government-led bulk-buying program, a first-of-its-kind event that spotlights the intense financial pain inflicted by the state’s cost-cutting measures.
The Tianjin Medical Procurement Center announced recently that two companies selected in an inter-provincial alliance for orthopedic trauma products, Changzhou Dzhang Medical Device Co. and Changzhou Kangyu Medical Device Co., have gone bankrupt and can no longer supply their contracted products.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- DIGEST HUB
- September 2021:
- The national volume-based procurement (VBP) tender for artificial joints began, resulting in an average price cut of 82%.
- 2022:
- Subsequent VBP round for spinal products, with average price reductions of 84%.
- 2022:
- Wego Orthopaedic Device Co., Ltd. and Double Medical Technology Inc. both experienced significant revenue and net profit declines due to VBP pressures.
- 2022–2024:
- Beijing Wandong Medical Technology Co., Ltd. reported per-unit MRI machine production costs in this period.
- 2023:
- Further VBP round for sports medicine supplies, with average price reductions of 74%.
- 2023:
- Wego Orthopaedic Device Co., Ltd. revenue and net profit fell by 37.63% and 81.3% respectively; Shanghai Sanyou Medical Co., Ltd. reported revenue and net profit to have fallen 1.68% and 88.18% respectively for the most recent fiscal year.
- September 2023:
- Dzhang and Kangyu participated in a VBP tender for orthopedic trauma supplies covering 28 provinces/regions.
- October 2023:
- People’s Court of Wujin District in Changzhou accepted bankruptcy liquidation case for Kangyu.
- By 2025:
- If a supplier defaults, hospitals can select alternate winning bidders; Tianjin Medical Procurement Center required Dzhang and Kangyu to respond within 15 days or face contract loss and blacklisting.
- 2025:
- With the 11th round of national VBP approaching, China’s National Healthcare Security Administration announced new bidding rules to prevent vicious competition.
- First quarter of 2025:
- Chunlizhengda Medical Instruments Co., Ltd. and Sanyou Medical reported their first profit growth since VBP implementation.
- June 2025:
- People’s Court of Wujin District in Changzhou accepted bankruptcy liquidation case for Dzhang.
- PODCAST
- MOST POPULAR